Antibody-Cell Conjugation (ACC)
GPTKB entity
Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology technique
|
| gptkbp:appliesTo |
gptkb:T_cells
gptkb:natural_killer_(NK)_cells stem cells |
| gptkbp:enables |
cell surface modification
targeted cell delivery |
| gptkbp:firstDescribed |
early 2000s
|
| https://www.w3.org/2000/01/rdf-schema#label |
Antibody-Cell Conjugation (ACC)
|
| gptkbp:involves |
bio-orthogonal chemistry
chemical conjugation methods covalent attachment of antibodies to cells |
| gptkbp:purpose |
enhance therapeutic efficacy
redirect cell specificity |
| gptkbp:relatedTo |
antibody-drug conjugates
cell surface engineering |
| gptkbp:usedFor |
immunotherapy
infectious disease treatment autoimmune disease research |
| gptkbp:usedIn |
immunotherapy
gene therapy |
| gptkbp:bfsParent |
gptkb:Acepodia
|
| gptkbp:bfsLayer |
7
|